Profile and Organization

Names | Figures | Facts

Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials. As an innovation company, it sets trends in research-intensive areas. Bayer’s products and services are designed to benefit people and improve the quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power.

Bayer is committed to the principles of sustainable development and acts as a socially and ethically responsible corporate citizen. In fiscal year 2014, Bayer employed 118,900 people and had sales of €42.2 billion. Capital expenditures amounted to €2.5 billion, R&D expenses to €3.6 billion.

Organization

Bayer AG, Leverkusen, Germany, acts as a strategic management holding company. It defines the values, goals and strategies of the entire Group. It is also responsible for resource allocation and managerial appointments. Led by Bayer AG, the HealthCare, CropScience and MaterialScience subgroups independently manage their business operations in line with preset objectives. The Corporate Center supports the Group Management Board in its task of strategic leadership. The holding company and subgroups are supported in their activities by the three service companies Bayer Business Services, Bayer Technology Services and Currenta.


Bayer plans to increase the research and development investment to over

€4 billion

in 2015.

Business operations are the responsibility of the subgroups:

  • Bayer HealthCare is among the world’s foremost innovators in the field of pharmaceutical and medical products. more
  • Bayer CropScience is one of the world’s leading research-intensive companies in the agricultural industry, offering a broad range of innovative chemical and biological products for improving plant health, along with high-value seeds.more
  • Bayer MaterialScience is a renowned supplier of high-tech polymer materials such as polycarbonates and polyurethanes, and innovative system solutions for a wide range of everyday uses. Products holding leading positions on the world market account for a large proportion of its sales. more
     

Central service functions are combined into three service companies:
 

  • Bayer Business Services is the Bayer Group’s international competence center for it-based services. more
  • Bayer Technology Services is the global technological backbone for the Bayer Group and a major innovation driver. more
  • Currenta offers services for the chemical industry including utility supply, waste management, infrastructure, safety, security, analytics and vocational training. more

Corporate Governance

Dual governance system with the following governance bodies:

Board of Management:

five members, Chairman: Dr. Marijn Dekkers

Supervisory Board:

20 members, Chairman: Werner Wenning

Products

The Bayer Group markets some 5,000 products. Best-sellers include:

  • in the health care field: Xarelto™, Kogenate™, Betaferon™/Betaseron™/Mirena product family , Nexavar™
  • The key brands in the agriculture field are: Confidor™ / Gaucho™, Nativo™ product family, Nunhems™, Basta™/ Liberty™, Prosaro™ product family
  • Best-sellers in the field of high-tech polymer materials are: Makrolon™, Bayblend™, Desmodur™, Desmophen™

Locations

The Bayer Group comprises around 302 consolidated companies* in 75 countries throughout the world. Global headquarters are in Leverkusen, Germany.

* fully consolidated subsidiaries (as of Dec. 31, 2014)


Workforce

On December 31, 2014, the Bayer Group had 118,900 employees worldwide (2012: 112,400). In Germany we had 35,800 employees, who made up 30 percent of the Group workforce.

Employees

Bayer Stock


Bayer Group Key Data

   
  2013 2014 Change
  € million € million %
Bayer Group      
Sales 40,157 42,239 +5.2
EBIT1 4,934 5,506 +11.6
EBIT before special items2 5,773 5,944 +3.0
EBITDA3 7,830 8,442 +7.8
EBITDA before special items2 8,401 8,812 +4.9
EBITDA margin before special items4 20.9% 20.9%  
Income before income taxes 4,207 4,525 +7.6
Net income 3,189 3,426 +7.4
Earnings per share (€)5 3.86 4.14 +7.3
Core earnings per share (€)6 5.61 6.02 +7.3
Gross cash flow7 5,832 6,820 +16.9
Net cash flow8 5,171 5,810 +12.4
Net financial debt 6,731 19,612 .
Capital expenditures as per segment table 2,155 2,490 +15.5
Research and development expenses 3,406 3,574 +4.9
Dividend per Bayer AG share (€) 2.10 2.25 +7.1

figures restated
1-8 for definition see footnotes to Bayer Group Key Data table

(as of Dec. 31, 2014)

Share of Sales by Segment 2014 

Share of Sales by Segment 2013 (2012 in parentheses)

(as of December 31, 2014)

Last updated: May 5, 2015 Copyright © Bayer AG
http://www.bayer.com